drugset / Trial / NCT01905137

Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain

NCT01905137

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether there is a change in patient-reported pelvic pain following pelvic floor injections of 200 units of Botox compared with 20cc of normal saline.

Timeline

Start
2013-07
Primary completion
2018-03-09
Completion
2019-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 200 iu Intramuscular